Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 7, 2022
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
[ Mon, Nov 07th 2022
] - WOPRAI
Colin Langan Maintained (ADNT) at Buy with Increased Target to $42 on, Nov 7th, 2022
Colin Langan of Wells Fargo, Maintained "Adient plc" (ADNT) at Buy with Increased Target from $37 to $42 on, Nov 7th, 2022.
Colin has made no other calls on ADNT in the last 4 months.
There are 2 other peers that have a rating on ADNT. Out of the 2 peers that are also analyzing ADNT, 1 agrees with Colin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- John Murphy of "B of A Securities" Maintained at Hold with Decreased Target to $41 on, Friday, September 9th, 2022
This is the rating of the analyst that currently disagrees with Colin
- Adam Jonas of "Morgan Stanley" Maintained at Sell with Decreased Target to $27 on, Thursday, July 14th, 2022
